Skip to content

Comparison of Tramadol Orally Versus an Optimized Dose of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery

Comparison of the Therapeutic Efficacy and Side Effects of Tramadol Per os (Tradonal Odis® Orodispersible Tablets) Versus an Optimised Dosis of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00735748
Enrollment
195
Registered
2008-08-15
Start date
2008-03-01
Completion date
2009-06-19
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Patients who will undergo a general anesthesia for a procedure in short stay

Brief summary

The purpose of this study is to compare the administration of 1 unit dose of 50 mg tramadol perorally given in 3 unit dosages versus tramadol IV given in 3 unit dosage of 35 mg during the first 6 hours postoperatively and to investigate the time course and accuracy of pain relief versus the onset and duration of side effects. The first unit dose will be administered at arrival at the PACU when a Visual Analogue Pain (VAS) score of more than 3 is reached. The second and third unit dose will be administered after 1 and 2 hours, respectively, when a VAS of more than 3 is observed.

Interventions

DRUGTramadol per os (Tradonal Odis® orodispersible tablets)

Administration of 1 unit dose of 50 mg tramadol perorally given in 3 unit dosages

DRUGTramadol IV (Tradonal® IV)

Administration of tramadol IV given in 3 unit dosage of 35 mg

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* ASA I and II female or male patients undergoing wisdom teeth extraction * Aged 18-70 years * Scheduled for ambulatory surgery requiring postoperative pain medication

Exclusion criteria

* Weight less than 70% or more than 130% of ideal body weight * Neurological disorder * Recent use of psycho-active medication, including alcohol * Patients suffering from chronic pain receiving pre-operative pain medication including NSAID's * Use of chronic anti-emetic medication * Use of chronic corticoid therapy

Design outcomes

Primary

MeasureTime frame
Difference in pain score between groupsIn the first hours after anaesthesia and surgery

Secondary

MeasureTime frame
Difference in side-effects between the groupsIn the first hours after anaesthesia and surgery

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026